Dr. Carlos R. Sanabria

Internal Medicine
525 S. Silverbrook Dr., 
West Bend, WI 
525 S. Silverbrook Dr., 
West Bend, WI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Carlos Sanabria is a primary care provider, practicing in Internal Medicine in West Bend, Wisconsin. His top area of expertise is Long QT Syndrome.

His clinical research consists of co-authoring 16 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Internal Medicine
Licenses
Internal Medicine in WI
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Network Health
  • HMO

Locations

525 S. Silverbrook Dr., West Bend, WI 53095

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Phase 1, Randomized, Double-Blinded, Single-Dose Escalation Study Followed by a Multiple-Dose Escalation Study of SKL24741 in Healthy Subjects
A Phase 1, Randomized, Double-Blinded, Single-Dose Escalation Study Followed by a Multiple-Dose Escalation Study of SKL24741 in Healthy Subjects
Enrollment Status: Completed
Publish Date: December 21, 2023
Intervention Type: Drug
Study Phase: Phase 1
An Open-Label, Repeated-Dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of Oral CTAP101 Capsules, Immediate- Release (IR) Calcifediol, High-Dose Cholecalciferol, and Paricalcitol Plus Low-Dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Stage 3 or 4 Chronic Kidney Disease and Vitamin D Insufficiency
An Open-Label, Repeated-Dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of Oral CTAP101 Capsules, Immediate- Release (IR) Calcifediol, High-Dose Cholecalciferol, and Paricalcitol Plus Low-Dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Stage 3 or 4 Chronic Kidney Disease and Vitamin D Insufficiency
Enrollment Status: Completed
Publish Date: December 09, 2022
Intervention Type: Drug
Study Phase: Phase 4
A Phase I, Open-Label, Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intra-anal Application of Topical Oxymetazoline Gel in Healthy Adult Volunteers
A Phase I, Open-Label, Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intra-anal Application of Topical Oxymetazoline Gel in Healthy Adult Volunteers
Enrollment Status: Unknown
Publish Date: August 02, 2022
Intervention Type: Drug
Study Drug: Oxymetazoline
Study Phase: Phase 1
CSD190103: An Unblinded, Randomized, Multi-site, Two-way Crossover Study to Assess Nicotine Pharmacokinetic Parameters After Use of Two Smokeless Tobacco Products A19010-W and B19010-F in Healthy Adult Snus Consumers.
CSD190103: An Unblinded, Randomized, Multi-site, Two-way Crossover Study to Assess Nicotine Pharmacokinetic Parameters After Use of Two Smokeless Tobacco Products A19010-W and B19010-F in Healthy Adult Snus Consumers.
Enrollment Status: Completed
Publish Date: October 25, 2019
Intervention Type: Other
Study Phase: Not Applicable
CSD190102: An Unblinded, Randomized, Multi-site, Two-way Crossover Study to Assess Nicotine Pharmacokinetic Parameters After Use of Two Smokeless Tobacco Products A19010-R and B19010-O in Healthy Adult Snus Consumers.
CSD190102: An Unblinded, Randomized, Multi-site, Two-way Crossover Study to Assess Nicotine Pharmacokinetic Parameters After Use of Two Smokeless Tobacco Products A19010-R and B19010-O in Healthy Adult Snus Consumers.
Enrollment Status: Completed
Publish Date: October 25, 2019
Intervention Type: Other
Study Phase: Not Applicable
CSD190101: An Unblinded, Randomized, Multi-site, Two-way Crossover Study to Assess Nicotine Pharmacokinetic Parameters After Use of Two Smokeless Tobacco Products A19010-F and B19010-F in Healthy Adult Snus Consumers.
CSD190101: An Unblinded, Randomized, Multi-site, Two-way Crossover Study to Assess Nicotine Pharmacokinetic Parameters After Use of Two Smokeless Tobacco Products A19010-F and B19010-F in Healthy Adult Snus Consumers.
Enrollment Status: Completed
Publish Date: October 25, 2019
Intervention Type: Other
Study Phase: Not Applicable
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Potential Effect of a Single Oral Dose of Moxidectin on the Cardiac QT Interval of Healthy Volunteers
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Potential Effect of a Single Oral Dose of Moxidectin on the Cardiac QT Interval of Healthy Volunteers
Enrollment Status: Completed
Publish Date: March 14, 2019
Intervention Type: Drug, Other
Study Phase: Phase 1
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetic Study of Single-Ascending Doses of Intravenous Nafithromycin in Healthy Adult Subjects
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetic Study of Single-Ascending Doses of Intravenous Nafithromycin in Healthy Adult Subjects
Enrollment Status: Completed
Publish Date: August 01, 2018
Intervention Type: Drug
Study Phase: Phase 1
View 7 Less Clinical Trials

16 Total Publications

Characterization of Proteomic Pharmacodynamic Biomarkers of IFNβ-1a Biologics to Inform Potential Utility in Biosimilar Development.
Characterization of Proteomic Pharmacodynamic Biomarkers of IFNβ-1a Biologics to Inform Potential Utility in Biosimilar Development.
Journal: Clinical pharmacology and therapeutics
Published: March 28, 2025
Similar Doctors
Alok Srivastava
Expertise in
21
conditions
Dr. Alok Srivastava
Internal Medicine
Expertise in
21
conditions
Dr. Alok Srivastava
Internal Medicine

Aurora Internal Medicine

818 Forrest Ln, 
Waterford, WI 
 (44.9 miles away)
262-514-3700
Languages Spoken:
English
See accepted insurances

Alok Srivastava is a primary care provider, practicing in Internal Medicine in Waterford, Wisconsin. Dr. Srivastava is highly rated in 21 conditions, according to our data. His top areas of expertise are Hemophilia A, Blood Clots, Beta Thalassemia, Bone Marrow Aspiration, and Endovascular Embolization.

Jeffrey Bahr
Expertise in
455
conditions
Dr. Jeffrey Bahr
Internal Medicine
Expertise in
455
conditions
Dr. Jeffrey Bahr
Internal Medicine

Aurora Internal Medicine

3003 W Good Hope Rd, 
Milwaukee, WI 
 (22.4 miles away)
414-247-4622
Languages Spoken:
English
See accepted insurances

Jeffrey Bahr is a primary care provider, practicing in Internal Medicine in Milwaukee, Wisconsin. Dr. Bahr is highly rated in 455 conditions, according to our data. His top areas of expertise are Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, High Cholesterol, and Intrauterine Device Insertion.

Mark Y. Nunag
Expertise in
10
conditions
Dr. Mark Y. Nunag
Internal Medicine
Expertise in
10
conditions
Dr. Mark Y. Nunag
Internal Medicine

Midwest Nephrology Associates, SC

7793 W Appleton Ave, 
Milwaukee, WI 
 (24.0 miles away)
414-393-9810
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Mark Nunag is an Internal Medicine provider in Milwaukee, Wisconsin. Dr. Nunag is highly rated in 10 conditions, according to our data. His top areas of expertise are Acute Kidney Failure, Chronic Kidney Disease, End-Stage Renal Disease (ESRD), and Necrosis.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sanabria's expertise for a condition
ConditionClose
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile